SCHEMBL8015205

SCHEMBL8015205

O=C(O)COc1ccccc1CC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.61
ALDH1A1 P00352 2/20 0.58
MAPK1 P28482 1/20 0.58
PAM P19021 1/20 0.53
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GLA P06280 1/20 0.47
ELANE P08246 3/20 0.47
F2 P00734 1/20 0.47
PTGDR2 Q9Y5Y4 3/20 0.46
CFD P00746 1/20 0.46
PLG P00747 1/20 0.46
PLAU P00749 1/20 0.46
F11 P03951 1/20 0.46
KLKB1 P03952 1/20 0.46
F7 P08709 1/20 0.46
TPSB2 P20231 1/20 0.46
ITGB1 P05556 2/20 0.46
ITGA4 P13612 2/20 0.46
KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324677 0.89 L3MBTL1 (0.64) L3MBTL1ALDH1A1MAPK1CFDPLG
SCHEMBL8015222 0.84 L3MBTL1 (0.57) L3MBTL1ALDH1A1MAPK1PAMPOLB
SCHEMBL8682147 0.82 L3MBTL1 (0.54) L3MBTL1ALDH1A1MAPK1CFDPLG
SCHEMBL503961 0.81 L3MBTL1 (0.77) L3MBTL1ALDH1A1POLBSMN1; SMN2GLA
SCHEMBL6687005 0.80 ALDH1A1 (0.68) L3MBTL1ALDH1A1MAPK1PAMTDP1
SCHEMBL5661211 0.79 TBXAS1 (0.53) L3MBTL1ALDH1A1MAPK1CFDPLG
SCHEMBL9003138 0.79 HRH1 (0.61) L3MBTL1ALDH1A1MAPK1KDM4E
SCHEMBL1007508 0.78 CFD (0.68) L3MBTL1ALDH1A1CFDPLGPLAU
SCHEMBL4576519 0.78 L3MBTL1 (0.63) L3MBTL1ALDH1A1POLBSMN1; SMN2GLA
SCHEMBL31757965 0.78 CFD (0.68) L3MBTL1ALDH1A1CFDPLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6107284-A Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments PIERRE FABRE MEDICAMENT (FR) 2000-08-22 US disclosed